Related Experiment Videos
Cimetidine reduction of tumour formation in mice
Lancet (London, England)
|March 21, 1981
Abstract:
Cimetidine, a histamine type-2 receptor antagonist, had a protective effect in mice challenged with cells from two different syngeneic tumours. The results are a further indication of cimetidine's potential as an immunostimulator.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Drive-field Frequency Dependent MPI Performance of Single-Core Magnetite Nanoparticle Tracers.
IEEE transactions on magnetics·2015
Slew-rate dependence of tracer magnetization response in magnetic particle imaging.
Journal of applied physics·2014
Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.
Lancet (London, England)·2026
Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study.
Lancet (London, England)·2026
Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care.
Lancet (London, England)·2026
Post-diagnosis cannabis use and its association with health status and quality of life in cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Aloesin mitigates cisplatin-induced nephrotoxicity by suppressing NF-κB-mediated oxidative stress and modulating Bax/Bcl-2/caspase pathways.
Naunyn-Schmiedeberg's archives of pharmacology·2026